Patents Assigned to Luoxis Diagnostics, Inc.
-
Patent number: 9063070Abstract: The present invention provides a method of determining the overall oxidative status of a body fluid or a tissue of a patient by measuring the oxidation-reduction potential (ORP) of the body fluid or tissue. The method has been found to be useful in the diagnosis, evaluation and monitoring of patients who have suffered a trauma (such as a head injury), patients suspected of being critically-ill, patients who have a viral infection, and patients suspected of having a myocardial infarction. The method has also been found useful in monitoring and evaluating exercise performance in patients. In addition, the method has been found useful in monitoring and evaluating stored blood products and patients who will receive such a product.Type: GrantFiled: May 16, 2008Date of Patent: June 23, 2015Assignee: Luoxis Diagnostics, Inc.Inventors: David Bar-Or, Raphael Bar-Or
-
Patent number: 9034159Abstract: Methods and systems for measuring the oxidation-reduction potential of a fluid sample are provided. The system includes a test strip with a sample chamber adapted to receive a fluid sample. The sample chamber can be associated with a filter membrane. The test strip also includes a reference cell. The oxidation-reduction potential of a fluid sample placed in the sample chamber can be read by a readout device interconnected to a test lead that is in electrical contact with the sample chamber, and a reference lead that is in electrical contact with the reference cell. Electrical contact between a fluid sample placed in the sample chamber and the reference cell can be established by a bridge. The oxidation-reduction potential may be read as an electrical potential between the test lead and the reference lead of the test strip.Type: GrantFiled: December 30, 2013Date of Patent: May 19, 2015Assignee: Luoxis Diagnostics, Inc.Inventors: Raphael Bar-Or, David Bar-Or, Leonard T. Rael
-
Publication number: 20140291169Abstract: The present invention provides a method of determining the overall oxidative status of a body fluid or a tissue of a patient by measuring the oxidation-reduction potential (ORP) of the body fluid or tissue. The method has been found to be useful in the diagnosis, evaluation and monitoring of patients who have suffered a trauma (such as a head injury), patients suspected of being critically-ill or who are critically ill, patients who have an infection, and patients suspected of having a myocardial infarction (MI) or who have had an MI. The method has also been found useful in monitoring and evaluating exercise performance in patients. In addition, the method has been found useful in monitoring and evaluating stored blood products and patients who will receive such a product.Type: ApplicationFiled: March 21, 2014Publication date: October 2, 2014Applicant: Luoxis Diagnostics, Inc.Inventors: David Bar-Or, Raphael Bar-Or
-
METHODS AND SYSTEMS FOR MEASURING AND USING THE OXIDATION-REDUCTION POTENTIAL OF A BIOLOGICAL SAMPLE
Publication number: 20140121158Abstract: Methods and systems for measuring and using the oxidation-reduction characteristics of a biological sample are provided. The system generally includes a test strip and a readout device. A fluid sample is placed in the test strip, and the test strip is in turn operatively connected to the readout device. The readout device provides a controlled current that is sent across the fluid in the sample chamber. In addition, the readout device identifies an inflection point or transition time at which the voltage between contacts of the test strip is changing at the highest rate. The oxidation-reduction capacity of the sample is taken as the integral of the current profile from the time at which current begins to be supplied to the sample to the identified transition time.Type: ApplicationFiled: October 23, 2013Publication date: May 1, 2014Applicant: Luoxis Diagnostics, Inc.Inventors: Raphael Bar-Or, David Bar-Or, Leonard T. Rael -
Patent number: 8709709Abstract: The present invention provides a method of evaluating a patient in a hospital prior to discharge to determine if the patient is or is not at risk of early readmission if the patient were to be discharged from the hospital. The invention also provides a method of evaluating and monitoring the condition of a patient after discharge from a hospital. Both methods comprise measuring the oxidation-reduction potential (ORP) of a body fluid of the patient, a tissue of the patient of both.Type: GrantFiled: November 24, 2009Date of Patent: April 29, 2014Assignee: Luoxis Diagnostics, Inc.Inventors: David Bar-Or, Raphael Bar-Or
-
METHODS AND SYSTEMS FOR MEASURING AND USING THE OXIDATION-REDUCTION POTENTIAL OF A BIOLOGICAL SAMPLE
Publication number: 20140110273Abstract: Methods and systems for measuring and using the oxidation-reduction characteristics of a biological sample are provided. The system generally includes a test strip and a readout device. A fluid sample is placed in the test strip, and the test strip is in turn operatively connected to the readout device. The readout device provides a controlled current that is sent across the fluid in the sample chamber. In addition, the readout device identifies an inflection point or transition time at which the voltage between contacts of the test strip is changing at the highest rate. The oxidation-reduction capacity of the sample is taken as the integral of the current profile from the time at which current begins to be supplied to the sample to the identified transition time.Type: ApplicationFiled: October 23, 2013Publication date: April 24, 2014Applicant: Luoxis Diagnostics, Inc.Inventors: Raphael Bar-Or, David Bar-Or, Leonard T. Rael -
Publication number: 20140110257Abstract: Methods and systems for measuring the oxidation-reduction potential of a fluid sample are provided. The system includes a test strip with a sample chamber adapted to receive a fluid sample. The sample chamber can be associated with a filter membrane. The test strip also includes a reference cell. The oxidation-reduction potential of a fluid sample placed in the sample chamber can be read by a readout device interconnected to a test lead that is in electrical contact with the sample chamber, and a reference lead that is in electrical contact with the reference cell. Electrical contact between a fluid sample placed in the sample chamber and the reference cell can be established by a bridge. The oxidation-reduction potential may be read as an electrical potential between the test lead and the reference lead of the test strip.Type: ApplicationFiled: December 30, 2013Publication date: April 24, 2014Applicant: Luoxis Diagnostics, Inc.Inventors: Raphael Bar-Or, David Bar-Or, Leonard T. Rael
-
Patent number: 8641888Abstract: Methods and systems for measuring the oxidation-reduction potential of a fluid sample are provided. The system includes a test strip with a sample chamber adapted to receive a fluid sample. The sample chamber can be associated with a filter membrane. The test strip also includes a reference cell. The oxidation-reduction potential of a fluid sample placed in the sample chamber can be read by a readout device interconnected to a test lead that is in electrical contact with the sample chamber, and a reference lead that is in electrical contact with the reference cell. Electrical contact between a fluid sample placed in the sample chamber and the reference cell can be established by a bridge. The oxidation-reduction potential may be read as an electrical potential between the test lead and the reference lead of the test strip.Type: GrantFiled: October 24, 2012Date of Patent: February 4, 2014Assignee: Luoxis Diagnostics, Inc.Inventors: Leonard T. Rael, David Bar-Or, Raphael Bar-Or
-
Publication number: 20140004551Abstract: The present invention provides a method of determining the overall oxidative status of a body fluid or a tissue of a patient by measuring the oxidation-reduction potential (ORP) of the body fluid or tissue. The method has been found to be useful in the diagnosis, evaluation and monitoring of patients who have suffered a trauma (such as a head injury), patients suspected of being critically-ill, patients who have a viral infection, and patients suspected of having a myocardial infarction. The method has also been found useful in monitoring and evaluating exercise performance in patients. In addition, the method has been found useful in monitoring and evaluating stored blood products and patients who will receive such a product.Type: ApplicationFiled: September 3, 2013Publication date: January 2, 2014Applicant: Luoxis Diagnostics, Inc.Inventors: David Bar-Or, Raphael Bar-Or
-
Publication number: 20130277232Abstract: A multiple layer gel and method for forming a multiple layer gel are provided. The multiple layer gel includes an isolation layer and an electrolyte layer. The isolation layer provides a molecular weight screen, to prevent proteins or other molecules from contacting a reference cell covered by the isolation layer. The electrolyte layer covers the isolation layer, and provides a source of ions that place the reference cell in ionic and/or electrical contact with a fluid sample. The multiple layer gel can be used to maintain a reliable reference voltage from an associated reference cell while an electrical potential or other electrical characteristic of a sample fluid is being determined.Type: ApplicationFiled: April 19, 2013Publication date: October 24, 2013Applicant: Luoxis Diagnostics, Inc.Inventors: Raphael Bar-Or, David Bar-Or, Leonard T. Rael
-
Patent number: 8512548Abstract: The present invention provides a method of determining the overall oxidative status of a body fluid or a tissue of a patient by measuring the oxidation-reduction potential (ORP) of the body fluid or tissue. The method has been found to be useful in the diagnosis, evaluation and monitoring of patients who have suffered a trauma (such as a head injury), patients suspected of being critically-ill or who are critically ill, patients who have an infection, and patients suspected of having a myocardial infarction (MI) or who have had an MI. The method has also been found useful in monitoring and evaluating exercise performance in patients. In addition, the method has been found useful in monitoring and evaluating stored blood products and patients who will receive such a product.Type: GrantFiled: August 31, 2012Date of Patent: August 20, 2013Assignee: Luoxis Diagnostics, Inc.Inventors: David Bar-Or, Raphael Bar-Or